Cytotoxic effects of fucoidan nanoparticles against osteosarcoma

58Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

Abstract

In this study, we analyzed the size-dependent bioactivities of fucoidan by comparing the cytotoxic effects of native fucoidan and fucoidan lipid nanoparticles on osteosarcoma in vitro and in vivo. In vitro experiments indicated that nanoparticle fucoidan induced apoptosis of an osteosarcoma cell line more efficiently than native fucoidan. The more potent effects of nanoparticle fucoidan, relative to native fucoidan, were confirmed in vivo using a xenograft osteosarcoma model. Caco-2 cell transport studies showed that permeation of nanoparticle fucoidan was higher than native fucoidan. The higher bioactivity and superior bioavailability of nanoparticle fucoidan could potentially be utilized to develop novel therapies for osteosarcoma. © 2013 by the authors; licensee MDPI, Basel, Switzerland.

Cite

CITATION STYLE

APA

Kimura, R., Rokkaku, T., Takeda, S., Senba, M., & Mori, N. (2013). Cytotoxic effects of fucoidan nanoparticles against osteosarcoma. Marine Drugs, 11(11), 4267–4278. https://doi.org/10.3390/md11114267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free